As of 2026-05-21, the Fair Value of Bristol-Myers Squibb Co (BMY) is 73.18 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 58.54 USD, the upside of Bristol-Myers Squibb Co is 25.01%.
With the market price of 58.54 USD and our fair value calculation, Bristol-Myers Squibb Co (BMY) is a good investment. Investing in Bmy stocks now will result in a potential gain of 25.01%.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | 5Y Avg | |
| Net income | 6,994.00 | 6,327.00 | 8,025.00 | -8,948.00 | 7,054.00 | 3,890.40 |
| YoY growth | 177.58% | -9.54% | 26.84% | -211.50% | 178.83% | 32.44% |
| Market Cap (mil) | 119,523.46 |
| P/E | 20.00x |
| Forward P/E | 14.42x |
| EPS | 2.93 |
| Avg earnings growth rate | 32.44% |
| TTM earnings | 5,976.72 |